Case File №
#VI-2026-0552
PurePEPS
Request Full Data Access to the VendorInvestigator database of peptide tests.
Exhibit I
Compounds on File
37 LINE ITEMS| Compound | Grade | Samples | Mean | Min | Max | Latest |
|---|---|---|---|---|---|---|
| BPC-157 | B Good | 4 | 6.2 | 5.8 | 7.3 | 2 Mar 2025 |
| 5-amino-1MQ | X N/A | 1 | 7.0 | 7.0 | 7.0 | 9 Jun 2025 |
| ACE-031 | X N/A | 1 | 6.2 | 6.2 | 6.2 | 25 Apr 2025 |
| AHK-CU | X N/A | 1 | 5.0 | 5.0 | 5.0 | 28 Mar 2025 |
| Blend 300 (TRA/Mast P/Test P) | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Feb 2025 |
| Blend 500 (Tren E/Mast E) | X N/A | 1 | 4.3 | 4.3 | 4.3 | 2 Apr 2025 |
| BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | X N/A | 1 | 9.4 | 9.4 | 9.4 | 27 Feb 2025 |
| BPC157 5mg + TB500 5mg Blend | X N/A | 1 | 4.2 | 4.2 | 4.2 | 11 Jun 2025 |
| CJC-1295 With DAC | X N/A | 1 | 7.8 | 7.8 | 7.8 | 28 Mar 2025 |
| DSIP | X N/A | 1 | 4.3 | 4.3 | 4.3 | 13 Jun 2025 |
| Dutasteride | X N/A | 1 | 5.8 | 5.8 | 5.8 | 13 Jun 2025 |
| Enclomiphene | X N/A | 1 | 5.1 | 5.1 | 5.1 | 3 Jul 2025 |
| Equipoise (Boldenone Undecylenate) | X N/A | 1 | 6.6 | 6.6 | 6.6 | 28 Mar 2025 |
| HGH 191AA (Somatropin) | X N/A | 1 | 5.2 | 5.2 | 5.2 | 24 Apr 2025 |
| HMG | X N/A | 1 | 4.3 | 4.3 | 4.3 | 20 Jun 2025 |
| IGF-1 LR3 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 3 Jul 2025 |
| KissPeptin-10 | X N/A | 1 | 5.5 | 5.5 | 5.5 | 13 Feb 2025 |
| Lipo-C FAT BLASTER | X N/A | 1 | 6.6 | 6.6 | 6.6 | 20 Jun 2025 |
| NA Semax Amidate | X N/A | 1 | 9.4 | 9.4 | 9.4 | 11 Jun 2025 |
| NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | X N/A | 1 | 4.4 | 4.4 | 4.4 | 13 Feb 2025 |
| P21 | X N/A | 1 | 5.3 | 5.3 | 5.3 | 2 Jul 2025 |
| PEG MGF | X N/A | 1 | 5.9 | 5.9 | 5.9 | 17 Dec 2024 |
| Primobolan E Raw | X N/A | 1 | 4.0 | 3.8 | 3.8 | 25 Apr 2025 |
| Retatrutide 30mg Pen Kit | X N/A | 1 | 7.7 | 7.7 | 7.7 | 17 Dec 2024 |
| RIPEX 225 (TRA/Mast P/Test P) | X N/A | 1 | 7.2 | 7.2 | 7.2 | 21 May 2025 |
| Selank 10mg + Semax 10mg Blend | X N/A | 1 | 5.9 | 5.9 | 5.9 | 7 May 2025 |
| Selank | X N/A | 1 | 5.8 | 5.8 | 5.8 | 9 Jun 2025 |
| Semax | X N/A | 1 | 6.4 | 6.4 | 6.4 | 24 Apr 2025 |
| SNAP-8 | X N/A | 1 | 5.9 | 5.9 | 5.9 | 28 Mar 2025 |
| Superdrol | X N/A | 1 | 7.9 | 7.9 | 7.9 | 11 Jun 2025 |
| Supertest 450 | X N/A | 1 | 4.0 | 2.5 | 2.5 | 3 Jul 2025 |
| T3 (Liothyronine) | X N/A | 1 | 5.5 | 5.5 | 5.5 | 6 May 2025 |
| Tamoxifen (Nolvadex) | X N/A | 1 | 4.7 | 4.7 | 4.7 | 11 Jun 2025 |
| Turinabol | X N/A | 1 | 6.1 | 6.1 | 6.1 | 20 Jun 2025 |
| Winstrol Oil (Stanozolol) | X N/A | 1 | 4.0 | 3.2 | 3.2 | 3 Jun 2025 |
| Winstrol Oil | X N/A | 1 | 5.5 | 5.5 | 5.5 | 13 Jun 2025 |
| Winstrol (Stanozolol) | X N/A | 1 | 5.6 | 5.6 | 5.6 | 3 Jun 2025 |
Exhibit II
Evidence Log
40 LABORATORY RETURNS| Filed | Compound | Score | Claimed | Found | Δ Qty | Purity | Batch № | Lab | Source |
|---|---|---|---|---|---|---|---|---|---|
| 25 May 2026 | 5-amino-1MQ | 6.9 A | 2mg | 2.2mg | +9.7% | 97.71% | 4mkvjj | Lab C | Community |
| 25 May 2026 | Enclomiphene | 5.1 B | 100mg | 119.3mg | +19.3% | 97.15% | o3vtnp | Lab D | Public |
| 25 May 2026 | T3 (Liothyronine) | 5.8 B | 25mg | 24.7mg | -1.3% | 96.14% | ohca09 | Lab D | Public |
| 24 May 2026 | KissPeptin-10 | 4.9 C | 2mg | 1.7mg | -14.4% | 97.28% | s7c9fi | Lab C | Public |
| 24 May 2026 | NA Semax Amidate | 8.7 A | 50mg | 45.8mg | -8.5% | 99.21% | cfoggq | Lab E | Public |
| 24 May 2026 | SNAP-8 | 5.0 B | 20mg | 21.0mg | +5.0% | 97.67% | a3dj3d | Lab A | Public |
| 24 May 2026 | Primobolan E Raw | 5.0 B | 100g | 98.1g | -1.9% | 98.66% | 6x17di | Lab A | Community |
| 24 May 2026 | Dutasteride | 5.7 B | 25mg | 24.4mg | -2.6% | 99.26% | kkyf0h | Lab C | Public |
| 24 May 2026 | IGF-1 LR3 | 4.0 C | 15mg | 14.2mg | -5.3% | 96.94% | 11new9 | Lab G | Public |
| 24 May 2026 | Equipoise (Boldenone Undecylenate) | 4.2 C | 300mg/ml | 363.7mg/ml | +21.2% | 97.34% | 2brsxs | Lab E | Public |
| 24 May 2026 | Selank | 4.0 C | 2mg | 2.0mg | +2.0% | 95.44% | bvaltj | Lab C | Public |
| 23 May 2026 | Semax | 8.6 A | 30mg | 36.0mg | +20.0% | 98.11% | mq2d4g | Lab C | Community |
| 23 May 2026 | Winstrol Oil (Stanozolol) | 4.4 C | 200mg/ml | 232.3mg/ml | +16.2% | 99.18% | arvof4 | Lab C | Public |
| 23 May 2026 | CJC-1295 With DAC | 9.5 A | 30mg | 29.8mg | -0.7% | 96.71% | 51wrv2 | Lab F | Public |
| 21 May 2026 | P21 | 4.2 C | 30mg | 30.9mg | +2.9% | 96.82% | kjhi3k | Lab F | Community |
| 21 May 2026 | Winstrol Oil | 6.3 A | 250mg/ml | 221.7mg/ml | -11.3% | 99.76% | 98479u | Lab F | Public |
| 20 May 2026 | Tamoxifen (Nolvadex) | 4.0 C | 10mg | 9.7mg | -3.3% | 97.93% | y26g0j | Lab C | Public |
| 17 May 2026 | Blend 500 (Tren E/Mast E) | 5.2 B | 250mg/ml | 305.0mg/ml | +22.0% | 95.17% | 2qx1g8 | Lab B | Public |
| 19 Jan 2026 | ACE-031 | 6.1 A | 10mg | 8.7mg | -12.8% | 99.41% | iwbtm5 | Lab A | Public |
| 19 Jan 2026 | AHK-CU | 5.5 B | 30mg | 27.4mg | -8.6% | 95.58% | wo4o61 | Lab F | Community |
| 7 Jan 2026 | BPC157 5mg + TB500 5mg Blend | 4.0 C | 2mg | 2.2mg | +10.4% | 99.70% | iyv6a5 | Lab G | Public |
| 7 Jan 2026 | Selank 10mg + Semax 10mg Blend | 7.1 A | 20mg | 23.5mg | +17.5% | 98.88% | 0zhzhe | Lab G | Community |
| 6 Jan 2026 | HGH 191AA (Somatropin) | 6.9 A | 2mg | 2.2mg | +12.2% | 95.39% | gqmtpd | Lab F | Community |
| 6 Jan 2026 | PEG MGF | 6.1 A | 30mg | 32.7mg | +8.9% | 97.23% | hycgby | Lab E | Public |
| 6 Jan 2026 | Supertest 450 | 5.7 B | 200mg/ml | 231.1mg/ml | +15.5% | 95.55% | xg8rbn | Lab A | Public |
| 5 Dec 2025 | HMG | 4.0 C | 30mg | 28.5mg | -5.0% | 97.86% | n36abr | Lab F | Public |
| 5 Dec 2025 | Winstrol (Stanozolol) | 6.6 A | 20mg | 24.1mg | +20.5% | 95.61% | bd5sw7 | Lab E | Public |
| 23 Nov 2025 | Lipo-C FAT BLASTER | 7.2 A | 300mg/ml | 362.8mg/ml | +20.9% | 97.88% | fzxsa8 | Lab F | Community |
| 23 Nov 2025 | RIPEX 225 (TRA/Mast P/Test P) | 5.5 B | 100mg/ml | 107.2mg/ml | +7.2% | 98.79% | 8pzdb7 | Lab F | Public |
| 17 Nov 2025 | NAD+ 100mg + Mots-C 10mg + 5-Amino 1MQ 10mg Blend | 4.4 C | 10mg | 11.5mg | +14.7% | 95.97% | fmsfzx | Lab A | Community |
| 17 Nov 2025 | Retatrutide 30mg Pen Kit | 6.9 A | 30mg | 28.2mg | -6.0% | 97.87% | wdbev9 | Lab C | Public |
| 5 Nov 2025 | DSIP | 4.0 C | 30mg | 29.7mg | -1.0% | 99.27% | 13m6d1 | Lab F | Public |
| 9 Oct 2025 | Superdrol | 8.2 A | 50mg | 50.9mg | +1.7% | 95.34% | fsi8vp | Lab E | Community |
| 9 Oct 2025 | Turinabol | 7.9 A | 25mg | 25.5mg | +2.1% | 97.00% | cyi16e | Lab B | Public |
| 3 Oct 2025 | Blend 300 (TRA/Mast P/Test P) | 4.1 C | 300mg/ml | 300.8mg/ml | +0.3% | 99.93% | 3a9oxd | Lab A | Public |
| 3 Oct 2025 | BMK glycidic acid (P-2-P methyl glycidic acid / sodium salt) CAS 5449-12-7 | 9.2 A | 1g | 1.1g | +9.6% | 99.56% | oa04ze | Lab F | Public |
| 20 Mar 2025 | BPC-157 | 6.0 B | 5mg | 5.8mg | +16.0% | 99.23% | MA-9981129BP5 | Lab B | VendorInvestigator |
| 3 Mar 2025 | BPC-157 | 7.3 A | 5mg | 4.66mg | -6.8% | 98.90% | MA-9981129BP5 | Lab A | VendorInvestigator |
| 2 Mar 2025 | BPC-157 | 5.8 C | 5mg | 11.15mg | +123.0% | 99.81% | MA-9981129BP5 | Lab C | VendorInvestigator |
| 2 Mar 2025 | BPC-157 | 5.9 C | 5mg | 11.31mg | +126.2% | 99.87% | MA-9981129BP5 | Lab C | VendorInvestigator |
— END OF EVIDENCE LOG —